Released May 16, 2016, during market hours
10-Q filed May 16, 2016, 46 days after period end · 0001564590-16-019502
Q1 2016 · 10-Q
Revenue$1.62M$1.62M −0.4% vs Q1 2015−18.3% vs Q4 2015
Net Income-$14.57M-$14.57M N/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$5.19-$5.19 N/M vs Q1 2015no prior Q4 2015 on file
Operating Income-$1,167,000N/M
Operating Cash Flow-$1,969,000N/M
Free Cash Flowderived-$2,030,000N/M
Margins · derived
Operating margin-72.2%+49.0 pt vs Q1 2015
Net margin-901.8%−822.4 pt vs Q1 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $1.62M | $1.62M | $1.65M | $1.29M |
| Net Income | -$14.57M | -$1.29M | -$1.44M | -$1.71M |
| EPS Diluted | -$5.19 | -$1.07 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR